• Log In
Home
  • Home
  • About
  • Events
  • Jobs
  • News
  • People
  • Publications
  • Resources
  • Recent posts
Home

BioSpace.com

Syndicate content BioSpace.com
URL: http://www.biospace.com
Updated: 22 min 52 sec ago

Roche, Sign $637M Early-Stage Parkinson, Alzheimer Deal

Mon, 09/06/2010 - 20:00
LONDON, Sept 7 (Reuters) - Roche (ROG.VX) boosted its early-stage central nervous system (CNS) drug pipeline on Tuesday by signing a drug development deal for new Parkinson's and Alzheimer's disease medicines with Belgium's reMYND.
Categories: News

<b>Actis</b>, Sequoia Pharmaceuticals Said to Plan Sale of Stake in <b>Paras Pharmaceuticals</b> for Up to $700 Million

Mon, 09/06/2010 - 20:00
Bloomberg -- Actis Capital LLP and Sequoia Capital plan to sell a controlling stake in Indias Paras Pharmaceuticals Ltd. for as much as $700 million, according to three people with direct knowledge of the matter.
Categories: News

Idenix Pharmaceuticals, Inc. Hep C Drugs On Clinical Hold On Safety Concerns

Mon, 09/06/2010 - 20:00

CAMBRIDGE, Mass., Sept. 7 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that the company received verbal notice on Friday, September...

Categories: News

Valeant Pharmaceuticals International, Biovail Corporation to Cut 25 Pct Jobs Of Combined Company

Mon, 09/06/2010 - 20:00
Sept 7 (Reuters) - U.S.-based Valeant Pharmaceuticals International (VRX.N), which agreed to be bought by Canada's Biovail Corp (BVF.TO) in June, said they would cut about 25 percent of the combined company's U.S. and Canadian workforce as part of the integration plans.
Categories: News

FDA Relents from Midodrine Withdrawal Plan

Mon, 09/06/2010 - 20:00
AP -- NEW YORK Federal regulators have backed off a plan to remove a Shire PLC low blood-pressure treatment from the market after warning in August that the drug has not been proven effective.
Categories: News

Cockroach Brains May Be a Source of Antibiotics, University of Nottingham Study

Mon, 09/06/2010 - 20:00
Bloomberg -- Cockroach brains may be a source of new antibiotics capable of killing deadly drug-resistant bacteria, according to research that suggests the germ-spreading pests may be good for something after all.
Categories: News

Sanofi-Aventis (France) Prepares to Raise Genzyme Corporation Bid as GlaxoSmithKline Denies Plans to Step in as Rival Bidder

Mon, 09/06/2010 - 20:00
PARIS, Sept 7 (Reuters) - GlaxoSmithKline (GSK.L) will not step in as a rival bidder for U.S. biotech Genzyme (GENZ.O) and take on Sanofi-Aventis (SASY.PA), the British drugmaker's head of research and development told a French newspaper.
Categories: News

Pevion Biotech Ltd. Appoints New CEO and Secures CHF 10 Million ($9.9 Million) Financing

Mon, 09/06/2010 - 20:00
BERNE, Switzerland, September 7, 2010 /PRNewswire/ -- Pevion Biotech AG announced today the appointment of Evert Kueppers as its new Chief Executive Officer, succeeding Thomas Stauffer.

"We would like to thank Thomas for his excellent contributions over the years and wish him all the best in his new position," said Klaus Breiner of BB Biotech Ventures and Chairman of the Board of Directors...
Categories: News

Nonstick Cookware May Raise Kids' Cholesterol, West Virginia University Study

Mon, 09/06/2010 - 20:00
MedPage Today -- Kids who eat food cooked in nonstick pots and pans may have higher levels of LDL cholesterol, a large cross-sectional study found.
Categories: News

Alethia BioTherapeutics, Inc. Secures C$9.6 Million in Series A Financing to Fund Its Therapeutic Monoclonal Antibody Product Pipeline

Mon, 09/06/2010 - 20:00

MONTREAL, QUEBEC--(Marketwire - September 07, 2010) - Alethia Biotherapeutics Inc., a privately held Montreal-based biopharmaceutical company focused on the development of monoclonal antibodies ("mAbs") against therapeutic targets emanating from its STAR proprietary target discovery platform, announced today it has closed a C$9.6M Series A round of financing. Alethia will...

Categories: News

Medical Journal Urges U.K. to Pull GlaxoSmithKline's Diabetes Drug Avandia

Mon, 09/06/2010 - 20:00
Wall Street Journal -- The British Medical Journal on Monday said GlaxoSmithKline PLC's diabetes drug Avandia should never have been licensed and should be withdrawn from sale, a claim the company rejected.
Categories: News

Males at Greater Risk of Cognitive Impairment, Mayo Clinic Finds

Mon, 09/06/2010 - 20:00
MedPage Today -- Mild cognitive impairment may be more common in men than in women, a new study shows.
Categories: News

'Magic Mushrooms' Possible Tx in End-Stage Cancer, Harbor-UCLA Research and Education Institute (REI) Study

Mon, 09/06/2010 - 20:00
MedPage Today -- The active ingredient in "magic mushrooms" -- psilocybin -- may be useful to treat the anxiety and stress associated with end-stage cancer, researchers suggest.
Categories: News

Elan Corporation PLC Gets Injunction Against "Dissident" Directors

Mon, 09/06/2010 - 20:00
DUBLIN, Sept 7 (Reuters) - Elan (ELN.I) (ELN.N) said on Tuesday it has been granted an Irish High Court injunction to prevent two non-executive directors from launching a parallel probe into concerns over corporate governance at the drugmaker.
Categories: News

Cholera Outbreak in Cameroon 'Worst in 20 Years' Says

Mon, 09/06/2010 - 20:00
AP -- YAOUNDE, Cameroon UNICEF says more than 300 people have died in the West African nation of Cameroon from the country's worst cholera outbreak in 20 years.
Categories: News

Aurobindo Pharma in Pact With AstraZeneca PLC

Mon, 09/06/2010 - 20:00
Wall Street Journal -- BANGALORE -- Aurobindo Pharma Ltd. said Monday it has entered into agreements for licensing and supply of generic drugs to AstraZeneca PLC for sale in emerging markets, its second such deal with a prominent multinational drug maker.
Categories: News

Beckman Coulter, Inc. CEO Resigns, Named Interim CEO

Mon, 09/06/2010 - 20:00

ORANGE COUNTY, Calif., Sept. 7 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, today announced that Scott Garrett has resigned as Chairman, President...

Categories: News

FDA Drug Safety Communication: Increased risk of Death with Tygacil (tigecycline) Compared to Other Antibiotics Used to Treat Similar Infections

Mon, 09/06/2010 - 20:00
FDA -- [09-01-2010] The U.S. Food and Drug Administration (FDA) is reminding healthcare professionals of an increased mortality risk associated with the use of the intravenous antibacterial Tygacil (tigecycline) compared to that of other drugs used to treat a variety of serious infections. The increased risk was determined using a pooled analysis of clinical trials. The cause of the excess death in...
Categories: News

Late-night Workers are at Greater Risk for IBS, According to

Mon, 09/06/2010 - 20:00
Suburban Chicago News -- Bobby Chapman, of Seneca, is glad school is in session once again. A shift worker, Chapman knows he will be able to get better sleep when the house is empty and quiet during the day.
Categories: News

A Controlled Trial of Herbal Treatment for ADHD, Sheba Medical Center Study

Mon, 09/06/2010 - 20:00
Sharp Brains -- Many parents, health care professionals, and educators agree that there is a pressing need to develop effective treatments for ADHD to complement or substitute for traditional medication and behavior therapy approaches. This is because such treatments do not work for everyone, important difficulties often remain even when these treatments are effective, and...
Categories: News
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »

Associated Sites

  • Biotechnology Program
  • Columbia University
  • Columbia-Biotech Facebook Group
 
© COLUMBIA UNIVERSITY BIOTECHNOLOGY ASSOCIATION | Site Map | Website Feedback | Sponsors

Powered by
iMed Studios